AXSM · Axsome Therapeutics, Inc.
Market Cap
$10.83B
Shares
52.38M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-10 | 2026-06-30 | |
| 8-K | 2026-08-10 | — | |
| 8-K | 2026-07-15 | — | |
| 8-K | 2026-06-09 | 2026-06-05 | |
| 8-K | 2026-06-09 | 2026-06-05 | |
| Investor Event Transcript | 2026-06-08 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-06-03 | — | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 10-Q | 2026-05-04 | 2026-03-31 | |
| 8-K | 2026-05-04 | — | |
| 8-K | 2026-04-30 | — | |
| DEF 14A | 2026-04-24 | — | |
| 8-K | 2026-04-01 | — | |
| 10-K | 2026-02-23 | 2025-12-31 | |
| 8-K | 2026-02-23 | — | |
| 8-K | 2026-02-17 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-31 | — | |
| 8-K | 2025-11-03 | — | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-08-20 | 2025-08-19 | |
| 10-Q | 2025-08-04 | 2025-06-30 | |
| 8-K | 2025-08-04 | — | |
| 8-K | 2025-06-10 | — | |
| 8-K | 2025-06-09 | — | |
| 8-K | 2025-06-09 | 2025-06-06 | |
| 8-K | 2025-05-27 | — | |
| 8-K | 2025-05-13 | 2025-05-08 | |
| 8-K | 2025-05-05 | — | |
| 10-Q | 2025-05-05 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | — | |
| 8-K | 2025-04-01 | — | |
| 8-K | 2025-03-25 | — | |
| 8-K | 2025-03-05 | — | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-02-18 | — | |
| 10-K | 2025-02-18 | 2024-12-31 | |
| 8-K | 2025-02-10 | — | |
| 8-K | 2025-01-31 | 2025-01-30 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-30 | — | |
| 8-K | 2024-11-26 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-10-01 | 2024-09-30 | |
| 8-K | 2024-09-04 | — | |
| 8-K | 2024-08-21 | — | |
| 10-Q | 2024-08-05 | 2024-06-30 | |
| 8-K | 2024-08-05 | — |
Showing 1–50 of 180 filings
Key facts
CIK
1579428
CUSIP
05464T104
13F (30d)
327 filings
325 filers
Visit website
Investor relations